BECTON DICKINSON'S VISITEC ACQUISITION WOULD BOLSTER OPHTHALMIC SURGERY OFFERINGS, CREATE PLATFORM FOR FURTHER EXPANSION OF SURGICAL PRODUCTS BUSINESS
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson's planned acquisition of privately held ophthalmic surgery product firm Visitec would complement its existing Beaver Blade ophthalmic surgical blade business and add $20-25 mil. in annual revenues, Edward Ludwig, senior VP-finance and chief financial officer, told analysts Nov. 17 in New York City.